139 related articles for article (PubMed ID: 35995936)
1. HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
Aasbø G; Tropè A; Nygård M; Christiansen IK; Baasland I; Iversen GA; Munk AC; Christiansen MH; Presthus GK; Undem K; Bjørge T; Castle PE; Hansen BT
Br J Cancer; 2022 Nov; 127(10):1816-1826. PubMed ID: 35995936
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program.
Sahlgren H; Sparén P; Elfgren K; Miriam Elfström K
Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():68-73. PubMed ID: 34875556
[TBL] [Abstract][Full Text] [Related]
3. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of opt-in and send-to-all HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: The Equalscreen randomized controlled trial.
Knauss T; Hansen BT; Pedersen K; Aasbø G; Kunst N; Burger EA
Gynecol Oncol; 2023 Jan; 168():39-47. PubMed ID: 36371904
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia.
Veerus P; Hallik R; Jänes J; Jõers K; Paapsi K; Laidra K; Innos K
J Med Screen; 2022 Mar; 29(1):53-60. PubMed ID: 34694179
[TBL] [Abstract][Full Text] [Related]
6. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
[TBL] [Abstract][Full Text] [Related]
8. Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education.
Andersson S; Belkić K; Mints M; Östensson E
J Cancer Educ; 2021 Feb; 36(1):126-133. PubMed ID: 31522376
[TBL] [Abstract][Full Text] [Related]
9. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
[TBL] [Abstract][Full Text] [Related]
10. Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders.
Ejegod DM; Pedersen H; Pedersen BT; Serizawa R; Bonde J
Prev Med; 2022 Jul; 160():107096. PubMed ID: 35594924
[TBL] [Abstract][Full Text] [Related]
11. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.
Szarewski A; Cadman L; Mesher D; Austin J; Ashdown-Barr L; Edwards R; Lyons D; Walker J; Christison J; Frater A; Waller J
Br J Cancer; 2011 Mar; 104(6):915-20. PubMed ID: 21343937
[TBL] [Abstract][Full Text] [Related]
12. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches.
Ivanus U; Jerman T; Fokter AR; Takac I; Prevodnik VK; Marcec M; Gajsek US; Pakiz M; Koren J; Celik SH; Kramberger KG; Klopcic U; Kavalar R; Zatler SS; Kuzmanov BG; Florjancic M; Nolde N; Novakovic S; Poljak M; Zakelj MP
Radiol Oncol; 2018 Sep; 52(4):399-412. PubMed ID: 30216191
[TBL] [Abstract][Full Text] [Related]
13. HPV self-sampling and follow-up over two rounds of cervical screening in Australia - the iPap trial.
Sultana F; Gertig DM; English DR; Simpson JA; Drennan KT; Wrede CD; Mullins RM; Heley S; Saville M; Brotherton JM
J Med Screen; 2022 Sep; 29(3):185-193. PubMed ID: 35313763
[TBL] [Abstract][Full Text] [Related]
14. Sociodemographic characteristics associated with cervical cancer screening participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results from a randomized controlled trial among long-term non-attending women in Norway.
Hansen BT; Nygård M; Castle PE; Burger EA; Aasbø G
Int J Cancer; 2024 May; ():. PubMed ID: 38751040
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening.
Cadman L; Wilkes S; Mansour D; Austin J; Ashdown-Barr L; Edwards R; Kleeman M; Szarewski A
J Med Screen; 2015 Mar; 22(1):28-37. PubMed ID: 25403717
[TBL] [Abstract][Full Text] [Related]
16. Equal prevalence of severe cervical dysplasia by HPV self-sampling and by midwife-collected samples for primary HPV screening: a randomised controlled trial.
Hellsten C; Ernstson A; Bodelsson G; Forslund O; Borgfeldt C
Eur J Cancer Prev; 2021 Jul; 30(4):334-340. PubMed ID: 34010238
[TBL] [Abstract][Full Text] [Related]
17. Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening.
Costa S; Verberckmoes B; Castle PE; Arbyn M
Br J Cancer; 2023 Mar; 128(5):805-813. PubMed ID: 36517552
[TBL] [Abstract][Full Text] [Related]
18. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis between self-collected and clinician-collected samples for HPV testing in public health facilities in Zimbabwe.
Joseph J; Mangwendeza P; Maparo T; Mhizha T; Demke O; Murwira S; Dickson H; Madzima B; Khan S
J Clin Virol; 2021 Dec; 145():105017. PubMed ID: 34715579
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
